More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.
Read More
COVID-19 in North America
Housing California Annual Conference 2025
Join Abt Global and other leaders for the Housing California 2025 annual conference in Sacramento.
2025 Innovations and Solutions for Ending Unsheltered Homelessness (NAEH)
Meet the Abt Global team at NAEH’s 2025 Innovations and Solutions for Ending Unsheltered Homelessness conference in Los Angeles.
USAID Catalytic Action through Localized Policy Solutions (CATALYST)
USAID CATALYST is a global program that helps countries build policy and institutional frameworks that enable greater investment in sustainability and resilience across sectors.
Tracking Post COVID Conditions: Public Health Surveillance
Track PCC uses public health surveillance to learn more about the effects and burden of Long COVID among diverse populations.